Instead of an EBITDA of €4.5-4.7bn, management now expects it to come in at between €4.2bn and €4.5bn and instead of a ROCE of 11-12% it now sees it coming in at between 9% and 10%. Our current 2017 EBITDA projection is close to €4.7bn.
Management blames the overall economic situation for the profit warning. Industrial growth is lower than expected a year ago when the targets were set. In addition, state-controlled price reductions for the US healthcare market are contributing to this. Finall ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
2017 profit targets slashed
Instead of an EBITDA of €4.5-4.7bn, management now expects it to come in at between €4.2bn and €4.5bn and instead of a ROCE of 11-12% it now sees it coming in at between 9% and 10%. Our current 2017 EBITDA projection is close to €4.7bn.
Management blames the overall economic situation for the profit warning. Industrial growth is lower than expected a year ago when the targets were set. In addition, state-controlled price reductions for the US healthcare market are contributing to this. Finall ....